Get started
Author

Xinjing Ding

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications
2023 · Jianghua Ding, Xinjing Ding, et al. · Materials Today Bio · 24
LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma
2022 · Jianghua Ding, Xinjing Ding, et al. · Journal of Cancer · 19
PDF
Immunotherapy-based therapy as a promising treatment for EGFR-mutant advanced non-small cell lung cancer patients after EGFR-TKI resistance
2023 · Jianghua Ding, Xinjing Ding, et al. · Expert Review of Anticancer Therapy · 11
Effective treatment of apatinib for chemotherapy‑refractory advanced gastric carcinoma with AFP‑secretion and HER2‑positivity: A case report
2021 · Xinjing Ding, Jianghua Ding · Molecular and Clinical Oncology · 7
PDF
Aumolertinib challenge as an optional treatment in advanced non small‑cell lung cancer after osimertinib failure with epidermal growth factor receptor‑sensitive mutation: A case series
2022 · Xinjing Ding, Jianghua Ding, et al. · Oncology Letters · 5
PDF
Development and Validation of a Carbohydrate Metabolism-Related Model for Predicting Prognosis and Immune Landscape in Hepatocellular Carcinoma Patients
2024 · Hong-xiang Huang, Pei-yuan Zhong, et al. · Current Medical Science · 4
Long-acting granulocyte colony-stimulating factor in primary prophylaxis of early infection in patients with newly diagnosed multiple myeloma
2022 · Xinjing Ding, Jianghua Ding, et al. · Supportive Care in Cancer · 3
PDF
Anlotinib plus tislelizumab for recurrent metastatic pancreas ductal adenocarcinoma with germline BRCA2 mutation: A case report
2024 · Sujuan Peng, Hongxiang Huang, et al. · Experimental and Therapeutic Medicine · 1
PDF
Relationship Between the Proportion of CD24+ CD27+ B Cells And Lung Adenocarcinoma: Evidence From Mendelian Randomization And Single-Cell Analyses
2026 · Peiyuan Zhong, Jinhong Chen, et al. · Current Medicinal Chemistry
Case Report: Popliteal arterial tumor embolus as the initial presentation of EGFR-mutant lung adenocarcinoma with pulmonary-vein invasion
2025 · Yongchun Hong, Xinjing Ding, et al. · Frontiers in Oncology
PDF
Impact of Anti-angiogenic Drugs on Severity of COVID-19 in Patients with Non-Small Cell Lung Cancer
2024 · Sujuan Peng, Hongxiang Huang, et al. · Technology in Cancer Research & Treatment
Anlotinib plus Tislelizumab for Recurrent Metastatic Pancreas Ductal Adenocarcinoma with Germline BRCA2 Mutation: A Case and Literature Review
2023 · Sujuan Peng, Hongxiang Huang, et al. · Research Square
PDF
Works count: 12
Citation count: 74
H-index: 5
I10-index: 3
Year
Topic
Type